Oil's move to a six-week low has been cheering the stock market, but the question is for how long?    Read More

Following are the “Fast & Furious” trades - hot ways to play tomorrow's market moving events.   Read More

If only Merck could develop a treatment for this malady...   Read More

The debate about whether stocks are finding a floor is gaining momentum, but traders agree it's the earnings season that will help decide the details.    Read More

Winning sectors like coal have taken a hit. Who's on top now?   Read More

On another ugly day for the stock markets, beaten down shares of Dow component Merck rallied. The stock started picking up steam after the news broke late this morning that its late-stage experimental migraine headache drug essentially works just as well as an existing drug, but with fewer side effects.   Read More

Cramer makes the call on viewers' favorite stocks.   Read More

Tree huggers (just a colloquialism, not a dig) will be glad to know that biopharmaceutical companies submit their Food and Drug Administration filings for drug approval electronically these days.    Read More

As much as I tried to disconnect during my vacation last week, I couldn't escape the ubiquitous presence of pharmaceuticals in our everyday lives...   Read More

Cramer makes the call on viewers' favorite stocks.   Read More